The best over-the-counter weight loss pill with FDA approval is orlistat (Alli). It blocks some fat from being absorbed and can add modest weight loss when used with a reduced-calorie, lower-fat diet. Other OTC products are dietary supplements, not FDA-approved weight loss drugs, and they do not work like Ozempic or other GLP-1 medicines. 12
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →How did we evaluate the best OTC weight loss pills?
We ranked options by FDA status and human evidence, then weighed safety, realistic expectations, and whether a person can use the product with clinician or pharmacist guidance. A product being easy to buy does not prove that it works—or that it is safe with your current medicines. 12
That approach produces a short list. The only OTC medicine with FDA approval for weight loss is orlistat. Supplements may have a role in nutrition for some people, but they should not be presented as drug-level alternatives to GLP-1 treatment. 12
#1: Is Alli the best over-the-counter weight loss pill?
For someone specifically seeking an FDA-approved OTC weight loss medication, Alli (orlistat 60 mg) is the best-supported answer because it is the only one. It is intended for adults age 18 and older with a BMI of 25 or higher, alongside a reduced-calorie, lower-fat diet. 1
Best for: People who want a nonprescription medicine and can consistently follow a lower-fat eating pattern.
- FDA-approved for OTC weight loss use at the 60 mg strength. 1
- Works locally in the digestive tract rather than by suppressing appetite. 1
- Has modest average benefits compared with diet changes alone. 3
- Has predictable digestive side effects that may limit use. 1
How does orlistat work?
Orlistat is a lipase inhibitor. Lipases are digestive enzymes that help break down dietary fat. By blocking these enzymes, orlistat reduces absorption of roughly one-quarter of dietary fat from a meal; the unabsorbed fat leaves the body in stool. 1 Unlike GLP-1 receptor agonists, it does not act directly on appetite signals in the brain.
How much weight loss can Alli realistically support?
In a one-year randomized trial of orlistat used with dietary changes, people receiving orlistat lost more weight on average than those receiving placebo, though the difference was modest. The key point is that it is an add-on to food and activity changes—not a stand-alone solution—and individual results vary. 3
What are Alli's limitations and side effects?
The trade-off is digestive side effects, including oily spotting, fatty or oily stools, gas with discharge, more frequent bowel movements, and urgency. These effects are more likely after meals high in fat. Orlistat can also reduce absorption of vitamins A, D, E, and K and can interact with medicines including cyclosporine, levothyroxine, warfarin, and certain seizure medicines. 1
Orlistat should not be used during pregnancy. It is also contraindicated for people with chronic malabsorption syndrome or cholestasis. A pharmacist or clinician can help review whether it fits with your health history and medications. 1
#2: Can fiber supplements help with weight loss?
Soluble fiber can be a reasonable nutrition tool for fullness and regularity, but it is not an FDA-approved weight loss medication. Fiber absorbs water and can slow digestion, which may help some people feel satisfied with meals. 2
Best for: People who have low fiber intake and want to improve fullness or bowel regularity as part of a broader eating plan.
- Psyllium and glucomannan are common soluble-fiber ingredients. 2
- Fiber does not mimic semaglutide or activate the GLP-1 receptor like a medication. 2
- Bloating, gas, and constipation can occur, especially if fiber is increased quickly. 2
- Fiber can affect absorption of some medicines, so spacing and medication review matter. 2
The limitation is modest evidence. Fiber-rich foods are linked with health benefits, but supplement marketing often goes beyond what clinical trials can support for weight loss. If you use a fiber supplement, think of it as support for food habits—not as an OTC version of Ozempic. 2
#3: Do berberine or green tea extract work for weight loss?
Berberine and green tea extract are common ingredients in “metabolism” and “Ozempic alternative” marketing, but neither is an FDA-approved weight loss drug. Research findings are mixed, products vary widely, and these supplements can cause side effects or interact with medicines. 2
Best for: Neither should be considered a first-line substitute for an evidence-based medication evaluation when weight-related health risks are present.
- Berberine has been studied for metabolic markers and body weight, but study quality and product consistency vary. 6
- Green tea extract may contain concentrated catechins and caffeine; concentrated extracts have been linked to liver injury reports. 7
- Neither ingredient is a GLP-1 receptor agonist or a GLP-1/GIP dual receptor agonist. 2
- A supplement label does not mean the product has FDA drug approval or FDA-reviewed effectiveness. 2
Berberine can cause nausea, diarrhea, constipation, or stomach discomfort and may interact with medications. Green tea extract can cause stimulant effects when caffeine is present, and concentrated extracts have a liver-safety concern. Pregnancy is a reason to avoid self-starting weight loss products without clinician guidance. 67
What over-the-counter drug is like Ozempic?
There is no OTC drug equivalent to Ozempic. Ozempic is a brand of semaglutide, a prescription GLP-1 receptor agonist approved for type 2 diabetes; Wegovy is semaglutide approved for chronic weight management. OTC orlistat works through fat digestion, not the GLP-1 pathway. 14
Supplements sometimes called “nature's Ozempic”—often berberine, soluble fiber, and green tea extract—do not have the same mechanism, FDA approval, or clinical-trial evidence as prescription GLP-1 medicines. Claims that a supplement “mimics Ozempic” should be treated as marketing, not as proof of comparable results. 24
How do OTC and prescription weight loss medications compare?
The central difference is expected benefit and medical oversight. Alli has modest average effects and can be bought without a prescription. Prescription medications can have larger effects in trials, but they require screening for contraindications, side effects, drug interactions, and follow-up. 1345
| Option | What it is | Evidence and realistic expectation | Important limitations |
|---|---|---|---|
| Alli (orlistat 60 mg) | FDA-approved OTC drug | Modest additional weight loss with diet changes in clinical research. 13 | Oily stools, urgency, vitamin absorption concerns, and medication interactions. 1 |
| Fiber supplements | Dietary supplement | May support fullness; not an FDA-approved weight loss drug. 2 | Can cause gas or bloating and affect absorption of some medicines. 2 |
| Berberine or green tea extract | Dietary supplements | Limited, mixed research; not comparable to GLP-1 trial evidence. 26 | Potential interactions; green tea extract has liver-safety concerns. 67 |
| Semaglutide (Wegovy) | Prescription GLP-1 receptor agonist | STEP 1 reported a mean 14.9% body-weight reduction at 68 weeks with lifestyle intervention. 4 | GI effects and boxed thyroid-tumor warning; not for pregnancy or people with certain thyroid cancer histories. 4 |
| Tirzepatide (Zepbound) | Prescription GLP-1/GIP dual receptor agonist | SURMOUNT-1 reported mean reductions up to 20.9% at 72 weeks at the studied dose. 5 | GI effects and thyroid-related warning; requires clinical screening and follow-up. 5 |
| Compounded semaglutide or tirzepatide | Prescription compounded preparation | Results are not established for compounded formulations; FDA-reviewed outcomes data come from studies of approved products containing these active ingredients. 459 | Not FDA-approved; quality and regulatory requirements differ from FDA-approved products. 9 |
Who is a candidate for OTC weight loss medication?
Alli is labeled for adults age 18 and older with a BMI of 25 or higher, used with a reduced-calorie, lower-fat diet. BMI is a screening tool, not a full picture of health, so medications, medical conditions, pregnancy plans, and eating patterns still matter. 1
Prescription weight management medicines are commonly considered for adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure, type 2 diabetes, or obstructive sleep apnea. Professional guidance emphasizes pairing medication with nutrition, movement, and ongoing clinical care. 10
Talk with a clinician before choosing an OTC pill if you are pregnant or planning pregnancy, breastfeeding, have liver or kidney disease, take multiple medicines, have a history of pancreatitis or gallbladder disease, or have had an eating disorder. Pregnancy is a contraindication for the weight loss medications discussed here. 145
What prescription alternatives exist if OTC pills are not enough?
Prescription options include GLP-1 medicines and GLP-1/GIP medicines, as well as several older oral medications. They are not automatically right for everyone, but they have stronger evidence than OTC supplements for eligible patients. 4510
Semaglutide and compounded semaglutide
Semaglutide is a GLP-1 receptor agonist. Wegovy is the FDA-approved brand for chronic weight management, while Ozempic is FDA-approved for type 2 diabetes. In STEP 1, semaglutide 2.4 mg once weekly was associated with a mean 14.9% body-weight reduction at 68 weeks when used with lifestyle intervention. Nausea, vomiting, diarrhea, constipation, gallbladder disease, pancreatitis, and thyroid-related warnings are important considerations. 4
Compounded semaglutide may be prepared by a state-licensed 503A pharmacy under a prescription where clinically appropriate. It is not an FDA-approved product, and outcomes from FDA-reviewed Wegovy studies should not be assumed for a compounded formulation. 9 For a broader medication comparison, read our guide to the best GLP-1 medications for weight loss.
Tirzepatide and compounded tirzepatide
Tirzepatide is a dual GLP-1/GIP receptor agonist. Zepbound is FDA-approved for chronic weight management, and Mounjaro is FDA-approved for type 2 diabetes. In SURMOUNT-1, adults receiving tirzepatide at studied doses had mean weight reductions up to 20.9% at 72 weeks; nausea, diarrhea, constipation, vomiting, gallbladder disease, pancreatitis, and thyroid-related warnings remain part of the risk discussion. 5
Compounded tirzepatide is not FDA-approved, and trial outcomes for the approved brand should not be transferred to a compounded preparation. Learn more about comparing online care in our guide to the best way to get tirzepatide online. 9
Other prescription options
Other FDA-approved options include liraglutide (Saxenda), phentermine-topiramate (Qsymia), and bupropion-naltrexone (Contrave). These medicines have different mechanisms and safety limits: for example, some are not appropriate in pregnancy, uncontrolled high blood pressure, seizure disorders, glaucoma, or with certain psychiatric histories. Orforglipron, sometimes referred to as Foundayo in consumer searches, is not an OTC option; patients should confirm its current FDA labeling and availability with a clinician or pharmacist rather than relying on online product claims. 10
3-min quiz
Considering a prescription option?
At Chia, a licensed US provider can review your health history and goals online and decide whether treatment is clinically appropriate. We offer semaglutide by injection and tirzepatide as tablets or injections; microdosing plans are available when a provider determines they fit. A prescription requires a medical evaluation and is not guaranteed. Compounded medications are prepared by state-licensed US 503A pharmacies and are not FDA-approved.
How can I access prescription weight loss medication online?
A safe online path starts with a licensed-provider evaluation. The clinician reviews your health history, current medicines, BMI and related conditions, contraindications, and treatment goals before deciding whether a prescription is appropriate. Prescription weight loss medication should not come from a no-prescription “research chemical” seller or an unverified social-media source. 810
At Chia, the process is fully online: you complete a health questionnaire, a licensed US provider reviews it, and medication is prescribed only when clinically appropriate. For eligible patients, our provider-guided plans can include compounded semaglutide injections or compounded tirzepatide tablets or injections, with home delivery from state-licensed 503A compounding pharmacies and portal messaging between visits.
| Chia treatment option | Available form | Current starting price | What to know |
|---|---|---|---|
| Semaglutide | Injection | Plans currently start at $249/mo | Microdosing plans are available when clinically appropriate; provider-guided dosing and follow-up are included. |
| Tirzepatide | Tablets or injection | Tablets currently start at $249/mo; injections start at $299/mo | Microdosing plans are available when clinically appropriate; the provider helps determine the appropriate path. |
Insurance coverage and out-of-pocket costs vary widely, especially for weight management treatment. If you are comparing programs, look beyond the monthly price: confirm that a licensed clinician evaluates you, understand which pharmacy dispenses the medication, and ask how follow-up and side-effect support work. Our guide to comparing online weight loss medications can help you ask the right questions.
Frequently asked questions
Costs depend on the medication, pharmacy, insurance coverage, dose, and whether a program includes clinical follow-up. At Chia, compounded semaglutide injection plans currently start at $249 per month, while compounded tirzepatide plans start at $249 per month for tablets and $299 per month for injections.
3-min quiz
Talk through your weight management options
If OTC products have not been enough, a Chia provider can review your goals, medical history, and medication options in an online visit. We prescribe only where clinically appropriate, and a prescription is never guaranteed. Chia medications are compounded by state-licensed US 503A pharmacies and shipped to your door; compounded medications are not FDA-approved.
References
- 1.U.S. Food and Drug Administration. Alli (orlistat) Capsules, 60 mg: Prescribing Information. 2025.
- 2.U.S. Food and Drug Administration. Dietary Supplements: What You Need to Know. 2025.
- 3.Davidson MH, Hauptman J, DiGirolamo M, et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA. 1999.
- 4.Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021.
- 5.Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022.
- 6.Ye Y, Liu X, Wu N, et al. Efficacy and safety of berberine alone for several metabolic disorders: a systematic review and meta-analysis of randomized clinical trials. Frontiers in Pharmacology. 2021.
- 7.National Institutes of Health, LiverTox. Green Tea. 2024.
- 8.U.S. Food and Drug Administration. Tainted Weight Loss Products. 2025.
- 9.U.S. Food and Drug Administration. Understanding the Risks of Compounded Drugs. 2025.
- 10.Grunvald E, Shah R, Hernaez R, et al. AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity. Gastroenterology. 2022.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



